Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00920712

Enrollment

200

Registered

2009-06-15

Start date

2009-08-31

Completion date

2012-07-31

Last updated

2016-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastritis

Keywords

chronic atrophic gastritis, Traditional Chinese Medicine

Brief summary

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Interventions

DRUGWeiqi decotion

Decoction ,two times a day

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of Chronic Atrophic Gastritis * Male of female patients between 18-65 years old * Written informed consent

Exclusion criteria

* Combine with malignant pathology on epithelial dysplasia of gastric mucosa * Combine with duodenal ulcer or gastric ulcer * Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease. * Pregnancy or breast feeding women, or unwilling to have contraception.

Design outcomes

Primary

Measure	Time frame
Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change	12 weeks

Secondary

Measure	Time frame
Indicates of liver and renal function	12 weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026